Subacute Toxicity Study of Lacidipine Nanoformulation

被引：0

作者：

Shirodkar, Rupesh ^{[1
]}

Reddy, Neetinkumar ^{[2
]}

Kumar, Nitesh ^{[2
]}

Ramalingayya, Grandhi ^{[2
]}

Mutalik, Srinivas ^{[1
]}

Lewis, Shaila ^{[1
]}

机构：

[1] Manipal Univ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut, Manipal 576104, Karnataka, India

[2] Manipal Univ, Manipal Coll Pharmaceut Sci, Dept Pharmacol, Manipal 576104, Karnataka, India

来源：

LATIN AMERICAN JOURNAL OF PHARMACY | 2015年 / 34卷 / 08期

关键词：

lacidipine; solid lipid nanoparticles; subacute toxicity; EXTRACT; LEAVES;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The aim of the present work was to perform subacute toxicity study of lacidipine nanoformulation in Wistar rats. Solid lipid nanoparticles (SLNs) of lacidipine was formulated using ultrasound dispersion technique. Subacute toxicity study was carried out by administrating orally SLNs containing 0.140, 0.350, and 0.875 mg of lacidipine as low, medium and high dose per kg body weight, respectively, along with blank formulation and standard drug (lacidipine). Control group rats received Milli Q water. Doses were administered once daily over a period of 28 days. Animals were observed for morphological parameters of toxicity during study period and their body weight were recorded once weekly. Overnight fasted rats were sacrificed on 29th day and assessment of haematological, biochemical parameters and histopathological analysis of brain, heart, kidney and liver were carried out. The results suggest SLNs formulation of lacidipine do not cause toxicity or adverse effect in rats.

引用

页码：1526 / 1533

页数：8

共 20 条

[1] Preliminary toxicity and phytochemical studies of the stem bark aqueous extract of Musanga cecropioides in rats [J].

Adeneye, A. A. ;

Ajagbonna, O. P. ;

Adeleke, T. I. ;

Bello, S. O. .

JOURNAL OF ETHNOPHARMACOLOGY, 2006, 105 (03) :374-379

[2]

Akhand MM., 2010, Middle East Journal of Scientific Research, V5, P34

[3] Investigation into the toxicological effects of Catha edulis leaves:: a short term study in animals [J].

Al-Mamary, M ;

Al-Habori, M ;

Al-Aghbari, AM ;

Baker, MM .

PHYTOTHERAPY RESEARCH, 2002, 16 (02) :127-132

[4]

Andrade R. J., 2007, HEPATOL REV, V4, P14

[5]

[Anonymous], 2008, GUID TEST CHEM AC OR

[6]

Ayudhya T. Dechatiwongse Na, 2014, INT SCHOLARLY RES NO, P14

[7]

박준범, 2010, Journal of Pharmaceutical Investigation, V40, P9

[8]

KOCIBA RJ, 1976, TOXICOL APPL PHARM, V35, P553, DOI 10.1016/0041-008X(76)90078-8

[9] LACIDIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF HYPERTENSION [J].

LEE, CR ;

BRYSON, HM .

DRUGS, 1994, 48 (02) :274-296

[10] CLINICAL-POSITION OF LACIDIPINE, A NEW DIHYDROPYRIDINE CALCIUM-ANTAGONIST, IN THE TREATMENT OF HYPERTENSION [J].

LEONETTI, G .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 :S18-S21

← 1 2 →